Xinke Capital logo

Xinke Capital

Asia, Hunan, China, Xian

Description

Xinke Capital specializes on green energy, semiconductors, medical health, and smart manufacturing.

Investor Profile

Xinke Capital has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (40%)
  • Series Unknown (20%)
  • Series A (20%)
  • Series C (20%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Semiconductor
  • Hardware
  • Robotics
  • Advanced Materials
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Sensor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xinke Capital frequently co-invest with?

HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Coastal Fund
Asia, Hebei, China, Hebei
Co-Investments: 1
Co-Investments: 1
LC
North America, Texas, United States, Dallas
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
GLP Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Co-Investments: 1
Jingcheng Mechanical and Electrical
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Xinke Capital?

YMC Semiconductor

Wuxi Shi, Jiangsu, China

YMC Semiconductor is a manufacturer of semiconductor device special equipment.

SeedMar 10, 2025
Hongtu Semiconductor Technology

Beijing, Beijing, China

Hongtu Semiconductor Technology focuses on the CMOS image sensor chip design platform for producing CIS image sensors.

ManufacturingSemiconductorSensor
SeedAug 2, 2023
Amount Raised: $13,905,885
PIE Semiconductor

Hangzhou, Zhejiang, China

PIE Semiconductor is a third-generation semiconductor power device in China, mainly engaged in power device products.

Advanced MaterialsManufacturingSemiconductor
Series AJan 19, 2023
Amount Raised: $14,756,009
Zhitong Precision

Beijing, Beijing, China

Zhitong Precision is a manufacturer of robot reducers.

HardwareManufacturingRobotics
Series UnknownMar 16, 2022
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738